FDA Inspection 1260284 — Rowena C. Punzalan, M.D.

Rowena C. Punzalan, M.D. — FEI 3017812513

The FDA completed an inspection of Rowena C. Punzalan, M.D. on February 7, 2025 in Milwaukee, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 7, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Milwaukee, WI (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance